Navigation Links
Predictors Of Wound Infection In Ventral Hernia Repair

Abdominal wall hernias are one of the most common conditions treated by general surgeons, with more than 100,000 repairs// performed annually. Although ventral hernia repair (VHR) is a common operation, recurrences and complications remain a vexing problem. Wound infection has been identified as a consistent risk factor for recurrence after VHR.

A recent study, which appears in the November issue of The American Journal of Surgery was designed with the aim to identify predictors of postoperative wound infection in subjects undergoing VHR in a retrospective multicenter study of ventral hernia outcomes. The study examines patient- and procedure-specific variables associated with wound infection, and specifically focuses on the effect of mesh placement at VHR on postoperative wound complications.

For the study, a cohort of subjects undergoing VHR from 13 regional Veterans Health Administration (VHA) sites was identified. Patient-specific risk variables were obtained from National Surgical Quality Improvement Program (NSQIP) data. Operative variables were obtained from physician-abstracted operative notes. Univariate and multivariable logistic regression analysis was used to model predictors of postoperative wound infection.

A total of 1505 VHR cases were used for analysis; wound infection occurred in 5% (n = 74). Best-fit logistic regression models demonstrated that steroid use, smoking, prolonged operative time, and use of absorbable mesh, acting as a surrogate marker for a more complex procedure, were significant independent predictors of wound infection.

The results demonstrated that chronic steroid use, current smoking, prolonged operative time, and use of absorbable mesh (likely a marker for more complex intraoperative variables) were significant predictors of postoperative wound infection in VHR.

The only modifiable risk factor identified was current smoking. Smoking cessation prior to elective hernia repair may decrease the rate of wound infection and ultimately hernia recurrence. VHR remains a challenging problem for general surgeons. Mesh repair has been shown to decrease recurrence but is not systematically used. This study provides further evidence that use of permanent mesh prosthesis for VHR is not associated with increased wound complications in short-term follow-up. However, the authors state that long-term studies are needed to further verify the safety and efficacy of mesh use for ventral hernia repair.

About ventral hernia (Incisional Hernia):

A hernia is the protrusion of an organ through the wall that normally contains it. An incisional hernia occurs in the abdomen in the area of an old surgical scar. A part of an organ in the abdomen, such as the bowel or intestines, protrudes through the weakened area of the abdominal wall.
'"/>




Related medicine news :

1. Elevated LDL levels in Childhood could be Predictors of Heart Disease
2. Predictors for Type 2 Diabetes
3. Understanding The Predictors Of Prostate Cancer
4. Identifying Predictors Of Anthrax
5. Early Predictors Of Heart Disease
6. People With Genetic Predictors of Colorectal Cancer are Not Getting Screened
7. Wound healing made faster
8. Psychological Stress Delays Wound Healing
9. Wound healing affected by Psychological stress
10. Wound Healing Found To Be Slower In Couples Who Fight Often
11. ‘Marriage Squabbles’ bad for both Emotional and Physical Wound
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... ... February 17, 2017 , ... ... disruptive innovation in the industry, according to the recent NEJM Catalyst Insights Report ... surveys of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, ...
(Date:2/18/2017)... ... 18, 2017 , ... A new directory from the Senior ... easily connect elderly veterans of America's armed forces to a range of senior ... material on this year's increase in the Veterans Pension with Aid & Attendance ...
(Date:2/17/2017)... TN (PRWEB) , ... February 17, 2017 , ... ... Inc. (ISTS) brings its educational assistance management solution to the exhibit floor for ... Center in Orlando, Fla. , From Feb. 19–23, 2017, more than 40,000 ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... exhibitor at Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As ... showcase its anatomic and molecular pathology workflow solution, as well as its new ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... -- Noble Capital Markets announced today that it has initiated ... EPIX ). The report was issued by Noble,s Head ... ESSA Pharmaceuticals is a clinical stage biopharmaceutical company ... lead compound EPI-506, is a small molecule oral drug ... receptor, thereby has potential to overcome some of the ...
(Date:2/16/2017)... , Feb. 16, 2017 Quest Diagnostics ... of diagnostic information services, today announced that it has ... for 2017 by Fortune. The annual ... companies in the "Health Care: Pharmacy and Other Services" ... diagnostic information services company to attain the designation. This ...
(Date:2/16/2017)... , Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company, today announced that executive management will participate ... be held February 22-23, 2017. Adrian Adams , ... Company at 1:35 p.m. local time on Wednesday, February ... archive for the event may be accessed from the ...
Breaking Medicine Technology: